Devil in the detail: MET overexpression fails as surrogate marker for
MET
exon 14 splice site mutations in NSCLC
Ann Transl Med
.
2020 Dec;8(23):1612.
doi: 10.21037/atm-20-4253.
Authors
Matthew R Strickland
1
,
Pasi A Jänne
1
Affiliation
1
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
PMID:
33437811
PMCID:
PMC7791198
DOI:
10.21037/atm-20-4253
No abstract available
Publication types
Editorial
Comment
Grants and funding
R01 CA222823/CA/NCI NIH HHS/United States
T32 CA071345/CA/NCI NIH HHS/United States